Friday, March 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

Army Seeks Medical Device to Reduce Need for Trauma Fasciotomies

by Global Biodefense Staff
April 30, 2013

U.S. Army Medical CommandThe US Army Medical Research and Materiel Command (USAMRMC) is conducting market research on technology solutions for reducing the need for fasciotomies in trauma victims at risk for the development of extremity compartment syndrome. 

Compartment syndrome (CS) is a condition in which intramuscular pressure becomes sufficiently elevated to reduce myoneural blood flow to the point of causing tissue ischemia.  CS frequently occurs following trauma, ischemia or reperfusion injury, and prolonged tourniquet use in the extremity.

If untreated, CS causes permanent muscle and nerve injury, rhabdomyolysis and possible renal failure, and even death. Conditions in battlefield trauma facilities can make the diagnosis of CS difficult and can result in undiagnosed CS. The condition can also develop during air transport to medical treatment facilities.

Concerns for catastrophic outcomes due to delaying treatment or failing to diagnose CS have lead to a Department of Defense policy involving the liberal use of fasciotomies in at risk patients. However, fasciotomy is associated with a number of morbidities involving long-term consequences, including chronic venous insufficiency and limb swelling, deep vein thrombosis, tethering of overlying skin, surgical site infections, and pruritis. 

USAMRMC invites companies to respond with information about commercially available products, or products in development, that meet or can be readily modified to reduce the need for fasciotomy in patients at-risk for development of CS. 

Further details are available under Solicitation Number: MRMC-RFI-2013. The response deadline is May 28, 2013.

Tags: RFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC